Contineum Therapeutics, Inc. Class A Ownership | Who Owns Contineum Therapeutics, Inc. Class A?
Contineum Therapeutics, Inc. Class A Ownership Summary
Contineum Therapeutics, Inc. Class A is owned by 8.11% institutional investors, 1.10% insiders, and 90.78% retail investors. Suvretta capital management is the largest institutional shareholder, holding 10.26% of CTNM shares.
CTNM Ownership Benchmark
| Type | Name | % Inst | % Insiders | % Retail |
|---|---|---|---|---|
| Stock | Contineum Therapeutics, Inc. Class A | 8.11% | 1.10% | 90.78% |
| Sector | Healthcare Stocks | 232.80% | 10.63% | -143.43% |
| Industry | Biotech Stocks | 379.48% | 10.37% | -289.85% |
Institutional Shareholders
Top Institutional Shareholders by Total Shares
| Holder | Shares | % Holding | Value |
|---|---|---|---|
| Suvretta capital management | 2.84M | 10.26% | $37.11M |
| Janus henderson group | 2.73M | 9.87% | $35.59M |
| Johnson & johnson | 1.98M | 7.14% | $25.85M |
| Franklin resources | 1.84M | 6.64% | $24.02M |
| Balyasny asset management | 1.69M | 6.09% | $22.01M |
| Millennium management | 1.54M | 5.54% | $20.05M |
| Baker bros. advisors lp | 1.42M | 5.13% | $18.56M |
| Ra capital management | 1.30M | 4.68% | $16.93M |
| Perceptive advisors | 1.26M | 4.53% | $16.40M |
| Vanguard group | 1.27M | 4.52% | $14.53M |
Top Institutional Shareholders by % of Total Assets
| Holder | Shares | % Assets | Value |
|---|---|---|---|
| Sectoral asset management | 727.59K | 7.87% | $9.50M |
| Red tree management | 638.16K | 7.45% | $8.33M |
| Versant venture management | 542.63K | 5.01% | $7.09M |
| Johnson & johnson | 1.98M | 3.96% | $25.85M |
| Great point partners | 800.20K | 2.40% | $10.45M |
| Verdad advisers, lp | 86.03K | 1.26% | $1.12M |
| Suvretta capital management | 2.84M | 0.95% | $37.11M |
| Ikarian capital | 807.87K | 0.86% | $10.55M |
| Boxer capital management | 494.00K | 0.85% | $6.45M |
| Hhlr advisors | 669.34K | 0.52% | $8.74M |
Top Buyers
| Holder | Shares | % Assets | Change |
|---|---|---|---|
| Millennium management | 1.54M | 0.01% | 704.76K |
| Ikarian capital | 807.87K | 0.86% | 525.00K |
| Citadel advisors | 350.20K | 0.00% | 350.20K |
| Vanguard group | 1.27M | 0.00% | 306.63K |
| Janus henderson group | 2.73M | 0.02% | 285.86K |
Top Sellers
| Holder | Shares | % Assets | Change |
|---|---|---|---|
| Ra capital management | 1.30M | 0.18% | -883.70K |
| Commodore capital lp | - | - | -816.33K |
| Point72 asset management | 84.89K | 0.00% | -674.34K |
| Saturn v capital management | - | - | -319.35K |
| Stempoint capital lp | - | - | -265.83K |
New Positions
| Holder | Shares | % Assets | Change | Value |
|---|---|---|---|---|
| Citadel advisors | 350.20K | 0.00% | 350.20K | $4.57M |
| Vanguard fiduciary trust | 153.92K | 0.00% | 153.92K | $2.01M |
| Verdad advisers, lp | 86.03K | 1.26% | 86.03K | $1.12M |
| Dimensional fund advisors lp | 59.95K | 0.00% | 59.95K | $782.10K |
| Wellington management group llp | 55.61K | 0.00% | 55.61K | $726.25K |
Sold Out
| Holder | Change |
|---|---|
| Sbi securities | -1.00 |
| Ifp advisors | -1.00 |
| Srs capital advisors | -8.00 |
| Cubist systematic strategies | -24.00 |
| Golden state wealth management | -27.00 |
Institutional Ownership Trends
| Date | Holdings | Change % | Shares | Change % | Ownership | Change % | Increased Position | Change % | Decreased Position | Change % |
|---|---|---|---|---|---|---|---|---|---|---|
| Dec 31, 2025 | 10 | -83.87% | 2,281,353 | -86.95% | 8 | 0.18% | 7 | -77.42% | 1 | -94.74% |
| Sep 30, 2025 | 12 | -82.86% | 2,288,931 | -83.48% | 8 | 0.31% | 7 | -82.93% | 3 | -85.71% |
| Jun 30, 2025 | 69 | 13.11% | 13,845,129 | 2.06% | 53 | 1.94% | 40 | 42.86% | 21 | 16.67% |
| Mar 31, 2025 | 62 | 5.08% | 15,117,518 | -3.45% | 58 | 0.89% | 27 | -30.77% | 18 | 100.00% |
| Dec 31, 2024 | 60 | 17.65% | 15,782,189 | 16.07% | 81 | 2.92% | 40 | 66.67% | 9 | -40.00% |
Recent Insider Transactions
| Date | Name | Role | Activity | Value |
|---|---|---|---|---|
| May 01, 2026 | Lorrain Daniel S. | Chief Scientific Officer | Sell | $4.15K |
| May 01, 2026 | Lorrain Daniel S. | Chief Scientific Officer | Sell | $50.54K |
| Apr 06, 2026 | Lorrain Daniel S. | Chief Scientific Officer | Sell | $56.01K |
| Mar 02, 2026 | Lorrain Daniel S. | Chief Scientific Officer | Sell | $62.59K |
| Mar 02, 2026 | Watkins Tim | CMO & Head of Development | Sell | $54.22K |
Insider Transactions Trends
| Date | Buy | Sell |
|---|---|---|
| 2026 Q2 | - | 3 |
| 2026 Q1 | - | 15 |
| 2025 Q4 | - | 2 |
| 2025 Q2 | - | - |
| 2025 Q1 | - | - |
CTNM Ownership FAQ
Try Tickergate Pro Free
Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)
Customize your own personal stocks lists, views and charts
Choose from hundreds of fields, up to 15 years of history
Conduct deep comparison analysis
Discover trending investment themes
Find your next best investment
Research stocks using tools